CONSENT OF INDEPENDENT ACCOUNTANTS
We hereby consent to the incorporation by reference in each of the Registration Statements on Form S-1 (No. 333- 224039 and No. 333-234105), Form S-3 (No. 333-214868, No. 333-237808, No. 333-251255, No. 333-251256, and No. 333-257051) and Form S-8 (No. 333-193453, No. 333-196763, No. 333-207108, No. 333-213133, No. 333-219238, No. 333-227699, No. 333-233352, No. 333-237137, No. 333-249466, and No. 333-260120), of NightHawk Biosciences, Inc. of our report dated April 28, 2022 relating to the financial statements of Elusys Therapeutics, Inc. as of and for the year ended December 31, 2021, which appears in this Current Report on Form 8-K/A.
/s/Cherry Bekaert LLP
Raleigh, North Carolina
June6, 2022
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
NightHawk Biosciences Inc. published this content on 06 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 06 June 2022 20:51:11 UTC.